Wilmer Eye Institute
Baltimore, Maryland, 21287, United States
Location status: Recruiting
Location contact
Amir H Kashani, MD, PhD
PRINCIPAL_INVESTIGATOR
Ana Collazo Martinez
CONTACT
C
CONTACT
NCT Number: NCT04505618
This study will perform a prospective, longitudinal analysis of clinical and imaging findings from normal controls and subjects with retinal vascular disease to better define the diagnostic imaging criteria that signify change in disease stage. This includes disease progression in early stages of disease or disease regression with appropriate standard-of-care treatment.
Interested in participating?
Request Info18 year–99 year
All sexes
Interventional
Not applicable
Baltimore, Maryland, 21287, United States
Location status: Recruiting
Amir H Kashani, MD, PhD
PRINCIPAL_INVESTIGATOR
Ana Collazo Martinez
CONTACT
C
CONTACT
The objective of this study is to perform a prospective, longitudinal analysis of clinical and imaging findings from normal controls and subjects with retinal vascular disease to better define the diagnostic imaging criteria that signify change in disease stage. This includes disease progression in early stages of disease or disease regression with appropriate standard-of-care treatment.
Subjects will be identified from healthy subjects (seen for screening eye exams) and diseased subjects undergoing standard-of-care treatment or screening at eye clinic locations. The study population will include subjects with retinal vascular disease including but not limited to diabetic retinopathy, hypertension, retinal vein/arterial occlusion, and macular degeneration. Subjects who are enrolled will undergo non-invasive, minimal risk, FDA approved diagnostic imaging procedures to identify vascular changes.
The study methods will include retrospective review and collection of clinically approved imaging data that is obtained through standard-of-care methods for subjects who meet inclusion and exclusion criteria. Subjects who are identified in this manner will be asked to participate in a prospective study by each clinical study site.
The study end-points include the correlation of diagnostic imaging findings from Optical Coherence Tomography (OCT) based images with fundus photographs, clinical disease stage and visual acuity.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Exclusion criteria
Non-invasive, minimal risk, ocular imaging study
Other names: SS-OCTA
Non-invasive, minimal risk, ocular imaging study
Other names: SD_OCTA
Non-invasive, minimal risk, ocular imaging study
Non-invasive, minimal risk, ocular imaging study
Other names: Intraocular Lens (IOL) Master
Time frame: 5 years
Correlation of diagnostic imaging findings (vessel skeleton density) from OCT based images with disease stage
Contact information is provided by the study sponsor or research team.
Amir H Kashani, MD, PhD
CONTACT
Ana C Martinez, MPH
CONTACT
Johns Hopkins University
Other
Acronym: OCTA-RVD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01496625
Abnormalities, Multiple, Age-Related Macular Degeneration
Bethesda, Maryland, United States
View Trial DetailsNCT03680794
Cardiovascular Diseases, Diabetes Complications
Reims, France
View Trial DetailsNCT04008121
Cardiovascular Diseases, Diabetes Complications
Ann Arbor, Michigan, United States
View Trial DetailsNCT07002372
Age Related Macular Degeneration, CYSTOID MACULAR EDEMA
Hangzhou, Zhejiang, China
View Trial Details